MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Investigating the role of Parkin in mitigating oxidative stress

J.M. Tokarew, D. El Kodsi, J.T. Tomlinson, M.G. Schlossmacher (Ottawa, ON, Canada)

Meeting: 2016 International Congress

Abstract Number: 834

Keywords: Oxidative stress, Parkinsonism

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: We are investigating the ability of Parkin protein to protect cells from oxidative stress (OS) and the mechanisms that underlie this function. We hypothesize Parkin modulates cellular redox state through direct interaction with oxidants.

Background: About 50 % of early-onset PD is caused by autosomal recessive mutations in the PARK2 gene. Unfortunately, no specific role for Parkin in vivo has been validated; however signs of OS have been reported in humans and animal models of the disease. (Palacino et al, 2004) The present research focuses on Parkin’s role in protecting cells from OS.

Methods: We tested whether Parkin is able to directly mitigate reactive oxygen species (ROS). (1) Antioxidant activity of recombinant Parkin protein was determined using a chemiluminescence assay where the amount of luminescence produced is proportional to the concentration of ROS present within the sample; (2) Parkin’s ability to protect cells from OS was determined using two methods in established cell models overexpressing Parkin. First, production of ROS within the cell was measured using a ROS-specific fluorophore, and second, oxidized and reduced glutathione levels were measured as an indication of the downstream effect of ROS on overall redox state in cells. In both these methods, OS was induced by treatment with H2O2.

Results: Our preliminary results suggest that Parkin possesses the capacity to function as an antioxidant. Although it was not able to reduce ROS levels, both the chemiluminescence assay and glutathione measurements post-OS indicate that Parkin can protect the cell from ROS (H2O2) induced OS. In the chemiluminescence assay, Parkin was found to be more effective than equimolar amounts of glutathione, which may explain its ability to lower glutathione oxidation.

Conclusions: This is the first study which assesses Parkin’s ability as an antioxidant. The results gathered thus far would suggest that Parkin plays a role in direct ROS migitation and supports some of our previous work suggesting that Parkin protects neurons from oxidizing forces. (LaVoie et al, 2007) Further investigation using different oxidizing forces, measurement of other OS markers and animal PD models are required to further validate our results.

To cite this abstract in AMA style:

J.M. Tokarew, D. El Kodsi, J.T. Tomlinson, M.G. Schlossmacher. Investigating the role of Parkin in mitigating oxidative stress [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/investigating-the-role-of-parkin-in-mitigating-oxidative-stress/. Accessed May 15, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/investigating-the-role-of-parkin-in-mitigating-oxidative-stress/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley